Comparison between alcohol‐ and hepatitis C virus‐related hepatocellular carcinoma: clinical presentation, treatment and outcome
Open Access
- 14 December 2015
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 43 (3) , 385-399
Abstract
Summary: Background: Hepatitis C virus (HCV) and alcohol abuse are the main risk factors for hepatocellular carcinoma (HCC) in Western countries.Aim: To investigate the role of alcoholic aetiology on clinical presentation, treatment and outcome of HCC as well as on each Barcelona Clinic Liver Cancer (BCLC) stage, as compared to HCV‐related HCCs.Methods: A total of 1642 HCV and 573 alcoholic patients from the Italian Liver Cancer (ITA.LI.CA) database, diagnosed with HCC between January 2000 and December 2012 were compared for age, gender, type of diagnosis, tumour burden, portal vein thrombosis (PVT), oesophageal varices, liver function tests, alpha‐fetoprotein, BCLC, treatment and survival. Aetiology was tested as predictor of survival in multivariate Cox regression models and according to HCC stages.Results: Cirrhosis was present in 96% of cases in both groups. Alcoholic patients were younger, more likely male, with HCC diagnosed outside surveillance, in intermediate/terminal BCLC stage and had worse liver function. After adjustment for the lead‐time, median (95% CI) overall survival (OS) was 27.4 months (21.5–33.2) in alcoholic and 33.6 months (30.7–36.5) in HCV patients (P = 0.021). The prognostic role of aetiology disappeared when survival was assessed in each BCLC stage and in the Cox regression multivariate models.Conclusions: Alcoholic aetiology affects survival of HCC patients through its negative effects on secondary prevention and cancer presentation but not through a greater cancer aggressiveness or worse treatment result. In fact, survival adjusted for confounding factors was similar in alcoholic and HCV patients.Keywords
Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Bayer HealthCare
This publication has 48 references indexed in Scilit:
- Clinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinomaBMC Cancer, 2013
- Delayed Diagnosis of HCC with Chronic Alcoholic Liver DiseaseLiver Cancer, 2012
- Hepatocellular Carcinoma Risk Factors and Disease Burden in a European Cohort: A Nested Case-Control StudyJNCI: Journal of the National Cancer Institute, 2011
- Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in ItalyHepatology, 2010
- Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus‐related cirrhosisJournal of Gastroenterology and Hepatology, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinomaJournal of Hepatology, 2005
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- A Model to Predict Survival in Patients With End–Stage Liver DiseaseHepatology, 2001
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987